Short answer
Humana (HUM) filed its Q1 2026 10-Q quarterly report on Apr 29, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $39.6B (up 23.5% year over year) with net income of $1.2B.
Q1 2026 key financials · XBRL
- Revenue
- $39.6B
- +23.5% YoY
- Net income
- $1.2B
- −4.7% YoY
- Operating margin
- 4.4%
- EPS (diluted)
- $9.83
- −4.6% YoY
Source: XBRL data from the Humana (HUM) Q1 2026 10-Q on SEC EDGAR. USD.
Humana Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Total revenue $39.648B, up $7.536B or 23.5% YoY from $32.112B
- Operating margin 4.4% vs 6.3% YoY; benefit ratio 89.4% vs 87.0%
- Best line Primary care revenue $788M, up 68.0%; CenterWell worst margin 4.7% vs 7.7% YoY
- Net income $1.184B, down 4.7%; value-creation charges $98M vs $24M
- MaxHealth acquisition for approximately $908M; Star Ratings, v28 phase-in, and regulatory pressures remained headwinds
Risk Factors
- No new or changed risk factors; Humana incorporated the 2025 Form 10-K risk disclosures unchanged
- Regulatory and compliance exposure remains governed by carried-forward 10-K risks
- Near-term operational and competitive risks remain unchanged from the 2025 Form 10-K
- Share-repurchase liquidity commitment: $2.7 billion remaining under authorization through February 15, 2027
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Humana quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.